Zdrowie i gospodarka · 01/09/2005

FDA Requests Comments on Simultaneous Marketing of Prescription and Over-the-Counter Drugs

The FDA is seeking public input on whether to establish a rule allowing the simultaneous marketing of prescription and over-the-counter versions of the same active ingredient, as outlined in section 503(b) of the Federal Food, Drug, and Cosmetic Act.